Somatosensory migraine auras evoked by bihemispheric cortical spreading depression events in human parietal cortex
- PMID: 39397399
- PMCID: PMC11563527
- DOI: 10.1177/0271678X241290606
Somatosensory migraine auras evoked by bihemispheric cortical spreading depression events in human parietal cortex
Abstract
Cortical spreading depression (CSD) is associated with pronounced alterations in cerebral blood flow. These alterations can be captured using high-field functional magnetic resonance imaging (fMRI). While compelling clinical and experimental data suggest that CSD is involved in the pathogenesis of migraine aura, the mechanistic intricacies remain poorly understood. Here, we use visual stimulus-induced blood oxygen level-dependent (BOLD) fMRI responses to characterize spatiotemporal alterations in cerebral blood flow during spontaneous attacks with migraine aura. Six adult participants diagnosed with migraine with aura underwent BOLD fMRI scans with a visual stimulation paradigm, consisting of flickering checkerboard stimulation. Our results revealed that auras with somatosensory symptoms corresponded with bilateral alterations of stimulus-induced BOLD responses in the somatosensory cortex, exhibiting anterior-to-posterior propagation and absence of antecedent occipital abnormalities. These altered stimulus-induced BOLD responses were bilateral, despite a unilateral manifestation of aura symptoms, and had no relationship with positive or negative aura symptoms. The bilateral abnormalities in stimulus-induced BOLD responses completes our current knowledge on migraine aura.
Keywords: Aura; BOLD; cortical spreading depression; fMRI; migraine.
Conflict of interest statement
Declaration of conflicting interestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: C.G. reports receiving speaker fees from Eli Lilly, Lundbeck, Novartis, and Teva, outside of the submitted work. H.A. reports receiving personal fees from Lundbeck and Teva, outside of the submitted work. H.M.A. reports receiving personal fees from Pfizer, outside of the submitted work. M.A. reports receiving personal fees from AbbVie, Amgen, Astra Zeneca, Eli Lilly, GlaxoSmithKline, Lundbeck, Novartis, Pfizer, and Teva, outside of the submitted work. M.A. also reports serving as an Associate Editor of Brain and The Journal of Headache and Pain.
Figures
References
-
- Ashina M. Migraine. N Engl J Med 2020; 383: 1866–1876. - PubMed
-
- Headache Classification Committee of the International Headache Society (IHS) The international classification of headache disorders, 3rd edition. Cephalalgia 2018; 38: 1–211. - PubMed
-
- Rasmussen BK, Olesen J. Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia 1992; 12: 221–228; discussion 186. - PubMed
-
- Russell MB, Olesen J. A nosographic analysis of the migraine aura in a general population. Brain 1996; 119 (Pt 2): 355–361. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous
